Hepatocyte growth factor (HGF) (scatter factor) is a potent mitogen for epithelial cells,' 2 particularly hepatocytes and biliary epithelial cells.34 Hepatocyte growth factor was first isolated from rat platelets,5 and its human gene homologue was characterised as a mature polypeptide composed of a 60 kilodalton a subunit linked by a single disulphide bridge to a 30 kilodalton P subunit. 6 The biological effects of HGF are mediated via a 190 kilodalton cell surface tyrosine kinase receptor, the proto-oncogene product cMET. 7 Besides the mitogenic actions of HGF, other biological properties, including morphogenesis,8 tumour cell cytotoxicity,9 neutrophil priming,'0 lymphocyte chemotaxis," enhancement of B cell immunoglobulin secretion, 12 metastasis, 13 and stimulation of growth of haematopoietic progenitor cells of bone marrow'4 have been reported. The effects of HGF on haematopoietic cells and the pathophysiological relevance remain uncertain. However, the broad spectrum of biological effects demonstrated in vitro, coupled with the widespread expression of the cMET receptor on a variety of cell types, suggest that HGF may have significant effects on haematopoietic cell function and differentiation.
In the present study we have used the promyelocytic cell line HL60 as a model to study the effects of HGF on myeloid cell differentiation. We have also attempted to assess expression of cMET throughout differentiation. HL60 cells produce HGF when stimulated with low concentrations (1 -6 nM) of 12-0 tetradecanoylphorbol-1 3-acetate (TPA),"5 but the effect of autocrine production of HGF on expression of the cMET receptor remains unknown. Whilst it has been reported that HL60 cells co-cultured with HGF may assume similar morphological characteristics to neu- Briefly, MAC387 was localised as follows: firstly, endogenous peroxidase activity was blocked using 0-6% hydrogen peroxide in methanol, and non-specific binding of immunoglobulin was blocked with non-immune H NE serum (1 in 10 dilution). Cytospins were then incubated with monoclonal mouse antihuman MAC387 (1 in 50 dilution) followed by biotinylated rabbit antimouse immunoglobulins B and streptavidin/biotin/HRP complexes. Bound antibody was subsequently visualised with diaminobenzidine substrate. Human neutrophil elastase and cathepsin B were localised using polyclonal sheep anti-HNE or cathepsin B followed by biotinylated goat antisheep immunoglobulins and streptavidin/biotin/HRP complexes, and visualised as described above. e Between stages, slides were washed three times with phosphate buffered saline. The cMET receptor was immunolocalised using a double antibody method, rabbit anti-cMET followed by alkaline phosphatase labelled swine antirabbit immunoglobulins. did not reach statistical significance, suggesting that HGF had no effect on cell proliferation (fig 2A) . After two to three days in culture, the cells treated with DMSO stopped dividing ( fig 2B) and 3A) . After a further three days in culture, the untreated cells showed an increase in intensity of staining ( fig  3B) , indicating that cMET expression increased spontaneously with time. Cells treated with DMSO for three days also showed immunoreactivity for cMET and remained nonadherent to the culture wells (table) . When exposed to low or high concentrations of TPA, strong, evenly distributed cMET expression was observed and the cells became adherent to the culture wells (table) . Cells treated with HGF also expressed cMET strongly after 72 hours (table and fig 3C) . On visual assessment, cMET expression appeared to increase following culture with either TPA or HGF compared with control cells (table 1 and fig 3C) .
Discussion
The present study has compared the effects of HGF on myeloid cell differentiation with those observed with the standard differentiating agents DMSO and TPA. cursor cells. Nevertheless, our study demonstrates that, in isolated culture systems, exogenous HGF may commit myeloid precursor cells to monocytic differentiation, but its effects are distinct from those elicited by TPA. It has been shown previously that low concentrations of TPA (1-6 nM) induce production of HGF by this cell line, but higher concentrations (16 nM) do not.'5 We confirmed this in our experiments by monitoring HGF production after TPA treatment with a specific ELISA assay (data not shown). In HL60 cells HGF synthesis appeared to be induced only by the lower (1 -6 nM) concentration, an occurrence which may be related to the dose dependent effects ofTPA on protein kinase C isoform activation, as shown in other cell systems. 
